chuminhua2020-06-01 20:30
5/30,Menlo Therapeutics公司$Menlo Therapeutics(MNLO)$ 宣布,美国FDA已批准其全资子公司Foamix Pharmaceuticals开发的米诺环素局部疗法Zilxi(1.5% minocyline,FMX103)上市,治疗酒渣鼻成人患者。新闻稿指出,Zilxi是首款获得美国FDA批准治疗酒渣鼻成人患者的米诺环素局部疗法。Zilxi是该公...查看全文
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-03-20 AccNo: 0001564590-19-008561 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Menlo Therapeutics(MNLO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-02-28 AccNo: 0001564590-19-005451 Size: 9 MB 网页链接
$Menlo Therapeutics(MNLO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-02-28 AccNo: 0001564590-19-005528 Size: 741 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-02-27 AccNo: 0001564590-19-004902 Size: 153 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Menlo Therapeutics(MNLO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001104659-19-008621 Size: 66 KB 网页链接
$Menlo Therapeutics(MNLO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001104659-19-008624 Size: 85 KB 网页链接
$Menlo Therapeutics(MNLO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0000930413-19-000570 Size: 76 KB 网页链接
$Menlo Therapeutics(MNLO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0000315066-19-001157 Size: 7 KB 网页链接
$Menlo Therapeutics(MNLO)$ EFFECT - Notice of Effectiveness Filed: 2019-02-12 AccNo: 9999999995-19-000201 Size: 1 KB 网页链接
$Menlo Therapeutics(MNLO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001274173-19-000059 Size: 8 KB 网页链接